Loading…
Loading…
VSQTF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for VSQTF and 80,000+ other tickers.
See exactly how VSQTF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for VSQTF and 80,000+ other tickers.
Victory Square Technologies Inc. functions as a private equity and venture capital firm, primarily focused on nurturing, acquiring, and investing in nascent and early-stage companies. It empowers these ventures by supplying crucial senior leadership and vital resources for growth. Through its various portfolio companies, the firm engages with an extensive range of advanced technological fields, including blockchain, Web3, the creator economy, metaverse technologies, machine learning, climate tech, artificial intelligence, and virtual/augmented reality. Additionally, its interests encompass…
VANCOUVER, BC and LAS VEGAS, Aug. 27, 2026 /PRNewswire/ -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a rapidly growing digital health platform and provider of compliant healthcare infrastructure across the United States, today announced that the Company will release its second quarter 2026 financial results after market close on Monday, August 31, 2026. Management will host an investor webcast and conference call on Tuesday, September 1, 2026 at 6:00 a.m.
VANCOUVER, BC, Aug. 6, 2026 /PRNewswire/ -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a healthcare technology company operating a nationwide physician-supervised healthcare platform with a network of more than 300 licensed physicians, more than 3,000 licensed nurses, and pharmacy partners serving all 50 U.S. states, is pleased to announce that it has been invited to participate in Canaccord Genuity's 46th Annual Growth Conference, taking place August 11–13, 2026, at the InterContinental Boston in Boston, Massachusetts. The Canaccord Genuity Growth Conference is one of North America's premier institutional investor conferences, bringing together leading public and private growth companies with institutional investors from around the world across the technology, healthcare & life sciences, sustainability, industrials, and consumer sectors.
VANCOUVER, BC, July 29, 2026 /PRNewswire/ -- Victory Square Technologies Inc. ("Victory Square", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6) is providing shareholders with an update following today's news release issued by Hydreight Technologies Inc. ("Hydreight") regarding the recommendations of the U.S. Food and Drug Administration ("FDA") Pharmacy Compounding Advisory Committee ("PCAC") relating to certain peptide-related bulk drug substances. Victory Square is Hydreight's largest shareholder, holding 23,891,515 common shares, representing approximately 44.5% of Hydreight's issued common shares.
VANCOUVER, BC and LAS VEGAS, July 29, 2026 /PRNewswire/ -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (FSE: SO6) (OTCQB: HYDTF), a digital health platform connecting healthcare providers, pharmacies and patients across the United States, today provided an update on its peptide healthcare platform following the recent recommendations of the U.S. Food and Drug Administration's ("FDA") Pharmacy Compounding Advisory Committee ("PCAC"). During its July 23–24, 2026 meeting, the PCAC recommended that six peptide-related bulk drug substances—BPC-157, KPV, TB-500, MOTS-c, Semax and Epitalon—be considered for inclusion on the FDA's Section 503A Bulks List.
Victory Square Reports Q1 2026 Financial Results and Provides Portfolio Update PR Newswire VANCOUVER, BC, June 1